CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $668,000 | -73.6% | 2,650 | -44.4% | 0.00% | -100.0% |
| Q1 2022 | $2,533,000 | -13.7% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,934,000 | -39.6% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,861,000 | -35.9% | 4,766 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $7,578,000 | -19.3% | 4,766 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $9,389,000 | +57.6% | 4,766 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $5,957,000 | -30.6% | 4,766 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $8,578,000 | -78.5% | 4,766 | 0.0% | 0.00% | -81.8% |
| Q2 2020 | $39,984,000 | +60.1% | 4,766 | 0.0% | 0.01% | +57.1% |
| Q1 2020 | $24,973,000 | -24.6% | 4,766 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $33,113,000 | -77.9% | 4,766 | -84.5% | 0.01% | -77.8% |
| Q3 2019 | $149,539,000 | -39.2% | 30,712 | -13.5% | 0.03% | -37.2% |
| Q2 2019 | $245,934,000 | – | 35,502 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |